Earnings Per Share - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands				12 Months Ended
		Dec. 01, 2021	May 04, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of antidilutive shares				0	0	0
Proceeds from issuance of common stock	[1]			$ 0	$ 0	$ 70,238
Riverview
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock issued to shareholders in acquisition (in shares)		4,519,776
Follow-on Public Offering
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares issued through follow-on public offering, net of underwriting discounts and offering expenses (in shares)			2,990,000
Common stock, price per share (in dollars per share)			$ 25.00
Proceeds from follow-on common stock public offering			$ 74,800
Proceeds from issuance of common stock			$ 70,200

[1] Shares issued in offering were net of expenses of $4.6 million.